Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)

Health, Health, Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 30, 2027
Response Due
Active
Status

Opportunity Overview

Germany – Pharmaceutical products – Open House Original discount agreements 2025-33 - Propranolol (Dosage form: Oral solution)

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyHealth, Health, Health
CountryGermany
CategoryPharmaceuticals
PublishedOctober 20, 2025
Procurement stageActive solicitation
Response dueDecember 30, 2027
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Valproinsäure, ATC N03AG01
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Prednisolon, ATC S01BA04 für die Zeit 01.02.2026 - 31.01.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Latanoprost + Timolol (ausschließlich Einzeldosen), ATC S01ED61 für die Zeit 01.06.2025 - 31.05.2027
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Glatirameracetat 40mg, als Fertigpen, ATC L03AX13
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-36 - Natalizumab (Darreichungsform zur subkutanen Injektion)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Raltegravir (ATC: J05AJ01)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tacrolimus, ATC D11AH01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Alfacalcidol, ATC A11CC03

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.